BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25327643)

  • 21. Hematocrit on cardiopulmonary bypass and outcome after coronary surgery in nontransfused patients.
    Ranucci M; Conti D; Castelvecchio S; Menicanti L; Frigiola A; Ballotta A; Pelissero G
    Ann Thorac Surg; 2010 Jan; 89(1):11-7. PubMed ID: 20103197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease.
    Mack MJ; Pfister A; Bachand D; Emery R; Magee MJ; Connolly M; Subramanian V
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):167-73. PubMed ID: 14752427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is female sex an independent risk factor for perioperative transfusion in coronary artery bypass graft surgery?
    Williams ML; Trivedi JR; Doughtie C; Slaughter MS
    J Am Coll Surg; 2011 Mar; 212(3):362-6. PubMed ID: 21356488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center.
    Moskowitz DM; Klein JJ; Shander A; Cousineau KM; Goldweit RS; Bodian C; Perelman SI; Kang H; Fink DA; Rothman HC; Ergin MA
    Ann Thorac Surg; 2004 Feb; 77(2):626-34. PubMed ID: 14759450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery bypass grafting in non-dialysis-dependent mild-to-moderate renal dysfunction.
    Weerasinghe A; Hornick P; Smith P; Taylor K; Ratnatunga C
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1083-9. PubMed ID: 11385375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood transfusion after on-pump coronary artery bypass grafting: focus on modifiable risk factors.
    De Santo LS; Amarelli C; Della Corte A; Scardone M; Bancone C; Carozza A; Grassia MG; Romano G
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):359-66. PubMed ID: 22719027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative predicted risk does not fully explain the association between red blood cell transfusion and mortality in coronary artery bypass grafting.
    Paone G; Brewer R; Theurer PF; Bell GF; Cogan CM; Prager RL;
    J Thorac Cardiovasc Surg; 2012 Jan; 143(1):178-85. PubMed ID: 22014719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
    Kapetanakis EI; Medlam DA; Boyce SW; Haile E; Hill PC; Dullum MK; Bafi AS; Petro KR; Corso PJ
    Eur Heart J; 2005 Mar; 26(6):576-83. PubMed ID: 15723815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
    Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Preoperative Anemia and Perioperative Transfusion on Surgical Outcomes After Gastrectomy for Gastric Cancer.
    Kouyoumdjian A; Trepanier M; Al Shehhi R; Cools-Lartigue J; Ferri LE; Lee L; Mueller CL
    J Surg Res; 2021 Mar; 259():523-531. PubMed ID: 33248671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-related quality of life after coronary artery bypass grafting surgery and the role of gender.
    Martin LM; Holmes SD; Henry LL; Schlauch KA; Stone LE; Roots A; Hunt SL; Ad N
    Cardiovasc Revasc Med; 2012; 13(6):321-7. PubMed ID: 23084324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lowest safe hematocrit level on cardiopulmonary bypass in patients undergoing coronary artery bypass grafting.
    DiMarco A; Vélez H; SoItero E; Magraner M; Bredy R
    Bol Asoc Med P R; 2011; 103(2):25-9. PubMed ID: 22111467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative outcomes of cardiac surgery patients with ongoing ticagrelor therapy: boon and bane of a new drug.
    Schotola H; Bräuer A; Meyer K; Hinz J; Schöndube FA; Bauer M; Mohite PN; Danner BC; Sossalla S; Popov AF
    Eur J Cardiothorac Surg; 2014 Aug; 46(2):198-205. PubMed ID: 24420365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery.
    Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Hu S
    Ann Thorac Surg; 2010 May; 89(5):1489-95. PubMed ID: 20417766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
    Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender is an essential determinant of blood transfusion in patients undergoing coronary artery bypass graft procedure.
    Shevde K; Pagala M; Kashikar A; Tyagaraj C; Shahbaz N; Iqbal M; Idupuganti R
    J Clin Anesth; 2000 Mar; 12(2):109-16. PubMed ID: 10818324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the use of cardiopulmonary bypass for isolated coronary artery bypass an independent predictor of mortality and morbidity in patients with severe left ventricular dysfunction?
    Qiu ZB; Chen X; Xu M; Shi KH; Jiang YS; Xiao LQ
    Chin Med J (Engl); 2008 Dec; 121(23):2397-402. PubMed ID: 19102956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
    Spiess BD; Ley C; Body SC; Siegel LC; Stover EP; Maddi R; D'Ambra M; Jain U; Liu F; Herskowitz A; Mangano DT; Levin J
    J Thorac Cardiovasc Surg; 1998 Sep; 116(3):460-7. PubMed ID: 9731788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nadir hematocrit during cardiopulmonary bypass: end-organ dysfunction and mortality.
    Loor G; Li L; Sabik JF; Rajeswaran J; Blackstone EH; Koch CG
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):654-662.e4. PubMed ID: 22507841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.